Many researchers are interested in utilizing state-of-the-art technologies such as microarray-based transcriptomic and genomic analyses to attempt to dissect molecular profiles. Within the past decade we have witnessed significant advancements in research that are directly associated with the output of the genome sequencing endeavor. The results of these achievements provide hope to investigators researching complex diseases like cancer. Alterations in genes causing these diseases may result in one or several genes having aberrant genomic profiles or even hundreds to thousands of genes with perturbed function. This can result in a mishmash of genomic profiles that is difficult to sort through, presenting a challenge to researchers attempting to elucidate the cause and effect of cancer. To assist BCMCC investigators with these issues, the Genomic Profiling Resource will integrate two existing Baylor College of Medicine (BCM) facilities to provide state-of-the-art access to transcriptional or genomic profiling using microarray technology. The Resource utilizes spotted glass microarrays and the commercially available Affymetrix GeneChip? platform and offers expert advice in experimental design, data analysis, and bioinformatics, as well as access to computing hardware and software. Services offered by the Resource include sample quality control, expression profiling with microarrays, quantitative (real time) PCR, access to a cDNA clone respository, comparative genomic hybridization on spotted arrays, SNP genotyping utilizing Affymetrix GeneChips, data analysis, training, and workshops. Led by Drs. Lisa White and Ching Lau, this Core will provide a cost-effective resource for Cancer Center researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-02
Application #
7664867
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
2
Fiscal Year
2008
Total Cost
$114,261
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Lyon, Deborah; Lapteva, Natasha; Gee, Adrian P (2018) Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples. Mol Ther 26:6-7
Yosef, Nejla; Vadakkan, Tegy J; Park, June-Hee et al. (2018) The phenotypic and functional properties of mouse yolk-sac-derived embryonic macrophages. Dev Biol 442:138-154
El-Shennawy, Lamiaa; Dubrovskyi, Oleksii; Kastrati, Irida et al. (2018) Coactivation of Estrogen Receptor and IKK? Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer. Cancer Res 78:974-984
Bhat, Raksha R; Yadav, Puja; Sahay, Debashish et al. (2018) GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast Cancer Res Treat 170:279-292
Kotlajich, Matthew V; Xia, Jun; Zhai, Yin et al. (2018) Fluorescent fusions of the N protein of phage Mu label DNA damage in living cells. DNA Repair (Amst) 72:86-92
Zhang, Yiqun; Yang, Lixing; Kucherlapati, Melanie et al. (2018) A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases. Cell Rep 24:515-527
McLaughlin, Lauren P; Rouce, Rayne; Gottschalk, Stephen et al. (2018) EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood 132:2351-2361
Agosto, Melina A; Anastassov, Ivan A; Wensel, Theodore G (2018) Differential epitope masking reveals synapse-specific complexes of TRPM1. Vis Neurosci 35:E001
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Xing, Zhen; Zhang, Yanyan; Liang, Ke et al. (2018) Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer. Cancer Res 78:4524-4532

Showing the most recent 10 out of 991 publications